Elasmogen secure £2 million funding
Elasmogen, which are part of the Deepbridge Life Sciences EIS portfolio, has commitment to a further £2 million investment from Deepbridge.
Elasmogen, which are part of the Deepbridge Life Sciences EIS portfolio, has commitment to a further £2 million investment from Deepbridge.
We are pleased to announce the appointment of three new members to the team; Harriet Brooke-Taylor, who joins Deepbridge as a Communications Manager; Matt Burns, who joins Deepbridge as our new Administration Team Leader; and Tori Bray, who joins Deepbridge as a Business Development Manager.
Zilico, which are part of the Deepbridge Life Sciences EIS portfolio, have been selected to be a part of the inaugural Digital North Accelerator Programme, facilitating adoption and spread of innovation.